Aeluma, Inc.
Business
Aeluma, Inc. develops high-performance semiconductors for sensing, communication, and computing applications using heterogeneous integration of compound semiconductor materials on large-diameter substrates. It offers photodetectors and photodetector arrays, wafer-scale manufacturing, rapid prototyping, engineering samples, small-volume chip deliveries, and R&D and non-recurring engineering services under customer and government contracts. Key business activities include its in-house R&D/manufacturing operations, partnerships with production-scale fabrication foundries and packaging firms, and engagement in government-sponsored development programs. Aeluma targets mobile and consumer electronics, AI, defense and aerospace, automotive, AR/VR, and quantum computing markets through direct sales and strategic system-integrator and foundry channels.
Summary from filing dated 2025-09-09
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 | FY 2020 2020-12-31 |
|---|---|---|---|---|---|---|
| Revenue | 5 | 919,000 | 193,339 | — | — | |
| Cost of revenue | 2 | 619,000 | 109,395 | — | — | |
| Research and development | 1 | 3 | 3 | 1 | — | |
| General and administrative | 4 | 2 | 3 | 2 | 11,670 | |
| Total operating expenses | 7 | 5 | 6 | 4 | — | |
| Loss from operations | −2 | −5 | −6 | −4 | — | |
| Interest income | 113,000 | 1,000 | 1,190 | 2,096 | — | |
| Amortization of discount on convertible notes | −715,000 | — | — | — | — | |
| Changes in fair value of derivative liabilities | −278,000 | — | — | — | — | |
| Total other income (expense), net | −880,000 | 1,000 | 130,103 | 281,823 | 1,000 | |
| Loss before income tax expense | −3 | −5 | −5 | −3 | −12,670 | |
| Income tax expense | — | — | — | — | 800 | |
| Net loss | −3 | −5 | −5 | −3 | −13,470 | |
| Net loss per share - basic (in Dollars per share) | −0.23 | −0.37 | −0.47 | −0.32 | −0.02 | |
| Net loss per share - diluted (in Dollars per share) | −0.23 | −0.37 | −0.47 | −0.32 | −0.02 | |
| Weighted average common shares outstanding - basic (in Shares) | 13 | 12 | 11 | 11 | 560,586 | |
| Weighted average common shares outstanding - diluted (in Shares) | 13 | 12 | 11 | 11 | 560,586 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 | FY 2021 2021-06-30 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 4 | 1 | 5 | — | — | |
| Certificate of deposit | 12 | — | — | — | — | |
| Accounts receivable | 962,000 | 60,000 | 189,239 | — | — | |
| Deferred compensation | — | 20,000 | 53,034 | 662,464 | 662,464 | |
| Prepaids and other current assets | 633,000 | 22,000 | 19,943 | 27,662 | 22,521 | |
| Total current assets | 17 | 1 | 5 | 4 | 7 | |
| Equipment | 2 | 2 | 1 | — | — | |
| Leasehold improvements | 547,000 | 547,000 | 546,864 | 464,362 | 12,420 | |
| Accumulated depreciation | −1 | −609,000 | −300,445 | −96,987 | — | |
| Property and equipment, net | 1 | 1 | 1 | 986,988 | — | |
| Intangible assets | 4,000 | 7,000 | 9,833 | 12,833 | 14,833 | |
| Right of use asset - operating | 836,000 | 962,000 | 351,013 | 476,370 | 729,176 | |
| Other assets | 13,000 | 13,000 | 13,014 | 13,014 | 65,069 | |
| Total assets | 19 | 4 | 7 | 6 | 9 | |
| Accounts payable | 361,000 | 317,000 | 461,797 | 114,100 | — | |
| Accrued expenses and other current liabilities | 206,000 | 181,000 | 133,092 | 101,351 | 61,384 | |
| Lease liability - operating, current portion | 138,000 | 129,000 | 162,210 | 156,988 | 157,141 | |
| Total current liabilities | 705,000 | 627,000 | 757,099 | 372,439 | 287,100 | |
| Lease liability - operating, long-term portion | 803,000 | 941,000 | 296,452 | — | — | |
| Total liabilities | 2 | 2 | 1 | 831,144 | 897,555 | |
| Commitments and contingencies | — | — | — | — | — | |
| Preferred stock, $0.0001 par value: 10,000,000 authorized, and none issued and outstanding at June 30, 2025 and 2024 | — | — | — | — | — | |
| Common stock, $0.0001 par value: 50,000,000 shares authorized as of June 30, 2025 and 2024, and 15,864,360 and 12,178,424 shares issued and outstanding as of June 30, 2025 and 2024, respectively | 2,000 | 1,000 | 1,282 | 1,066 | 1,054 | |
| Additional paid-in capital | 35 | 16 | 15 | 9 | 8 | |
| Accumulated deficit | −17 | −14 | −9 | −4 | −230,922 | |
| Total stockholders equity | 18 | 2 | 6 | 5 | 8 | |
| Total liabilities and stockholders equity | 19 | 4 | 7 | 6 | 9 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 | FY 2020 2020-12-31 |
|---|---|---|---|---|---|---|
| Amortization of deferred compensation | 20,000 | 33,000 | — | — | — | |
| Stock-based compensation expense | 2 | 732,000 | 448,444 | 204,011 | — | |
| Depreciation and amortization expense | 415,000 | 311,000 | — | 98,987 | — | |
| Accounts receivable | −902,000 | 129,000 | −189,239 | — | — | |
| Prepaids and other current assets | −611,000 | −2,000 | 7,719 | −5,141 | — | |
| Accounts payable | 44,000 | −144,000 | 347,697 | 45,525 | — | |
| Accrued expenses and other current liabilities | 22,000 | 48,000 | 67 | 6,382 | 9,207 | |
| Net cash used in operating activities | −1 | −3 | −4 | −2 | −1,377 | |
| Purchase of equipment | −161,000 | −322,000 | −590,043 | — | — | |
| Net cash used in investing activities | −161,000 | −322,000 | −672,545 | −955,667 | −106,228 | |
| Repurchase of common stock | — | −4,000 | — | — | — | |
| Proceeds from stock option exercise | 25,000 | — | — | — | — | |
| Proceeds from convertible notes issuance | 3 | — | — | — | — | |
| Proceeds from Public Offering, net of offering costs | 13 | — | — | — | — | |
| Net cash provided by (used in) financing activities | 16 | −4,000 | 6 | 161,930 | 145,701 | |
| Net change in cash and cash equivalents, and certificate of deposit | 14 | −4 | 1 | −3 | — | |
| Conversion of convertible notes to stockholders equity | 2 | — | — | — | — | |
| Conversion of derivative liabilities to stockholders equity | 2 | — | — | — | — |